glp-1 gastric intestinal obstruction legal team in louisiana A North Carolina woman was hospitalized for days after overdosing on a weight-loss injection prescribed online, as new data shows a nearly 1,500% surge GLP-1–related overdoses nationwide Louisiana lawmakers are considering a

Li, Y., Wang, S

GLP-1 receptor agonists, such as semaglutide (sold under the brand name Ozempic or Wegovy) and tirzepatide (brand name Mounjaro or Zepbound), are medications originally developed for diabetes and now approved for chronic weight management at specific doses

But for othersespecially those without ADHDthe stimulating effects can trigger anxiety, panic attacks, or sleep difficulties

That said, there are a few aging-related risks to understand before starting weight loss medications like Wegovy or Zepbound, including: Fall risk due to lost muscle mass Underdiagnosed hypoglycemia Nutritional deficiencies One of the biggest risks of GLP-1 agonist medications in the elderly population is loss of muscle mass because any weight loss will lead to loss of muscle mass, says Cynthia Odogwu, MD, a family and lifestyle medicine physician in Maryland

Over 1 in 3 people taking GLP-1s face barriers to access, including difficulty filling prescriptions most often due to shortages